Infezione da virus dell'epatite C (HCV) e trapianto renale

Translated title of the contribution: Hepatitis C virus and renal transplantation

F. Fabrizi, P. Martin, G. Lunghi, A. Aroldi, P. G. Messa

Research output: Contribution to journalArticle

Abstract

Liver disease has emerged as an important cause of morbidity and mortality after renal transplantation (RT). Hepatitis C virus (HCV) is the leading cause of liver disease after RT. The impact of HCV infection on patient and graft survival is currently a major concern. Retrospective studies with appropriate follow-up have mainly demonstrated that HCV positive patients have greater mortality compared to HCV negative recipients after RT. Novel investigations by large databases (United States Renal Data Systems (USRDS)) have shown that recipients of donor HCV-positive kidneys are at an independently increased risk of mortality, adjusted hazard ratio 2.12 (95% confidence interval (95% CI), 1.72-2.87, p

Original languageItalian
Pages (from-to)429-437
Number of pages9
JournalGiornale italiano di nefrologia : organo ufficiale della Società italiana di nefrologia
Volume21
Issue number5
Publication statusPublished - Sep 1 2004

Fingerprint

Hepacivirus
Kidney Transplantation
Mortality
Liver Diseases
Kidney
Graft Survival
Virus Diseases
Information Systems
Retrospective Studies
Tissue Donors
Databases
Confidence Intervals
Morbidity

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Infezione da virus dell'epatite C (HCV) e trapianto renale. / Fabrizi, F.; Martin, P.; Lunghi, G.; Aroldi, A.; Messa, P. G.

In: Giornale italiano di nefrologia : organo ufficiale della Società italiana di nefrologia, Vol. 21, No. 5, 01.09.2004, p. 429-437.

Research output: Contribution to journalArticle

@article{28edb41dec864b6ebafa5b543a7f0421,
title = "Infezione da virus dell'epatite C (HCV) e trapianto renale",
abstract = "Liver disease has emerged as an important cause of morbidity and mortality after renal transplantation (RT). Hepatitis C virus (HCV) is the leading cause of liver disease after RT. The impact of HCV infection on patient and graft survival is currently a major concern. Retrospective studies with appropriate follow-up have mainly demonstrated that HCV positive patients have greater mortality compared to HCV negative recipients after RT. Novel investigations by large databases (United States Renal Data Systems (USRDS)) have shown that recipients of donor HCV-positive kidneys are at an independently increased risk of mortality, adjusted hazard ratio 2.12 (95{\%} confidence interval (95{\%} CI), 1.72-2.87, p",
author = "F. Fabrizi and P. Martin and G. Lunghi and A. Aroldi and Messa, {P. G.}",
year = "2004",
month = "9",
day = "1",
language = "Italian",
volume = "21",
pages = "429--437",
journal = "Giornale italiano di nefrologia : organo ufficiale della Società italiana di nefrologia",
issn = "0393-5590",
publisher = "Wichtig Publishing Srl",
number = "5",

}

TY - JOUR

T1 - Infezione da virus dell'epatite C (HCV) e trapianto renale

AU - Fabrizi, F.

AU - Martin, P.

AU - Lunghi, G.

AU - Aroldi, A.

AU - Messa, P. G.

PY - 2004/9/1

Y1 - 2004/9/1

N2 - Liver disease has emerged as an important cause of morbidity and mortality after renal transplantation (RT). Hepatitis C virus (HCV) is the leading cause of liver disease after RT. The impact of HCV infection on patient and graft survival is currently a major concern. Retrospective studies with appropriate follow-up have mainly demonstrated that HCV positive patients have greater mortality compared to HCV negative recipients after RT. Novel investigations by large databases (United States Renal Data Systems (USRDS)) have shown that recipients of donor HCV-positive kidneys are at an independently increased risk of mortality, adjusted hazard ratio 2.12 (95% confidence interval (95% CI), 1.72-2.87, p

AB - Liver disease has emerged as an important cause of morbidity and mortality after renal transplantation (RT). Hepatitis C virus (HCV) is the leading cause of liver disease after RT. The impact of HCV infection on patient and graft survival is currently a major concern. Retrospective studies with appropriate follow-up have mainly demonstrated that HCV positive patients have greater mortality compared to HCV negative recipients after RT. Novel investigations by large databases (United States Renal Data Systems (USRDS)) have shown that recipients of donor HCV-positive kidneys are at an independently increased risk of mortality, adjusted hazard ratio 2.12 (95% confidence interval (95% CI), 1.72-2.87, p

UR - http://www.scopus.com/inward/record.url?scp=84941738740&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941738740&partnerID=8YFLogxK

M3 - Articolo

C2 - 15547874

AN - SCOPUS:84941738740

VL - 21

SP - 429

EP - 437

JO - Giornale italiano di nefrologia : organo ufficiale della Società italiana di nefrologia

JF - Giornale italiano di nefrologia : organo ufficiale della Società italiana di nefrologia

SN - 0393-5590

IS - 5

ER -